Human Research Protection Program: Policy
Monitoring the Consent Process
Adopted By: All Campus IRB
Adoption Date: November 10, 2005
Purpose: This
document describes when and how a UW-Madison IRB may arrange for the informed
consent process in research to be observed.
Policy
I. UW-Madison IRBs may require observation
of the consent process and the signing of consent forms, when appropriate, to
assure that investigators satisfy all federal, state and institutional
requirements for obtaining informed consent from participants in human subjects
research.
II. Observation of the consent process
will be required only if the IRB concludes that no other alternative action
will adequately protect prospective participants in the informed consent
process.
III. Factors that may cause UW-Madison
IRBs to consider monitoring of the consent process include, but are not limited
to, particular vulnerabilities of prospective participants, complexity of the
research, investigator conflicts of interest, prior complaints about the
consent process or prior findings of noncompliance.
IV. If a UW-Madison IRB determines that
monitoring of the consent process is appropriate, the IRB may designate one or
more of the following as a monitor:
A. an IRB member or members
B. a member or members of the IRB staff
C. another individual(s) in the organization who is not part of the
research team (e.g., the General Clinical Research Center’s (GCRC) Research
Subject Advocate), or
D. a neutral, uninvolved third party hired by the organization, investigator,
or sponsor.
V. UW-Madison’s Research Policy Office
(RPO) may also monitor the consent process in research as part of it periodic
audit of research activities. For more information, see, Internal Audit of
HRPP.
Procedure
VI. The decision whether to require
monitoring of the informed consent process will be made by the IRB after a
thorough review of:
A. the research protocol and IRB application, including the subject
population and the complexity of the research
B. the proposed consent process as described by the investigator
C. the consent documents
D. the qualifications and role of each individual who will be involved in
the consent process
E. all alternative actions that are available to assure protection of
participants in the informed consent process.